ORAL TYPE II COLLAGEN IN RHEUMATOID ARTHRITIS

这项研究的目的是确定口服治疗是否 II型胶原治疗显著改善了患者的 类风湿性关节炎的表现。这项研究是第二阶段/第三阶段。 使用四种不同剂量口服的双盲安慰剂对照试验 II型胶原蛋白，将在六个月内每天服用。这些 研究可能为口服耐受的可能作用提供新的见解。 用于治疗自身免疫性疾病。

The purpose of this study is to determine whether treatment with oral type II collagen treatment produces significant improvement in the manifestations of rheumatoid arthritis. The study is a phase II/III double-blind, placebo-controlled trial using four different doses of oral type II collagen which will be administered daily for six months. These studies may provide new insights into the possible role of oral tolerance in the treatment of autoimmune disease.